NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of the Early Development medical device testing ...

Labcorp has launched an offering that combines its diagnostic tests with a phlebotomy service from Getlabs to test consumers in their own homes. Earlier in the year, Getlabs announced its Series A ...

Community Health Systems on Tuesday sold some of its ambulatory outpatient laboratory services to Labcorp for approximately $194 million in cash before transaction expenses. The deal includes assets ...

Gilead Sciences hired Bristol Myers Squibb alum Bob Allen as head of omnichannel strategy and digital transformation for public affairs. Ralph Abraham, who is Louisiana‘s surgeon general, has been ...

BURLINGTON, N.C. - Labcorp (NYSE:LH) announced Monday the appointment of Victor Bulto to its Board of Directors, effective December 1, 2025. The $22 billion market cap laboratory services provider, ...

Bulto, President, U.S. of Novartis, brings global healthcare leadership and growth track record to support Labcorp's long-term strategy BURLINGTON, N.C., Nov. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: ...

Food intolerances, food sensitivities, and food allergies can all produce negative symptoms, ranging from undesirable to downright dangerous. Food intolerances can produce uncomfortable or ...

OLATHE, Kan.--(BUSINESS WIRE)--KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment of ...

Labcorp is a science and healthcare company that provides laboratory testing services worldwide. It also functions as a lab facility that conducts research, clinical studies, diagnostic testing, and ...

Management cited the divestiture and consolidation of non-core early development sites, resulting in a reduction of approximately $50 million in annual revenue. The company lowered its midpoint ...

Labcorp Holdings reported robust financial results for the third quarter of 2025, with adjusted earnings per share (EPS) surpassing expectations and revenue meeting forecasts. The company recorded an ...